Explore 3 Stock Ideas & Industry Insights Download Free Report

888-969-2592
Shopping Cart 0
countryflagCA
Login

Home CompaniesHims Hers Health Inc

Hims Hers Health Inc

Healthcare Drug Manufacturers - Specialty & Generic
PortfolioPortfolio WatchlistWatchlist
Company price
20.66 USD -2.28 ( 9.94%)
Last update at 2026-11-10T14:59:00Z
VOLUME
14212410
Market Cap
6497.78M

Momentum Score

…

Hims & Hers Health, Inc. operates as a consumer-first health and wellness platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, Canada, Germany, the Republic of Ireland, France, Spain, Australia, and internationally. The company offers a range of curated prescription and non-prescription health and wellness products and services available to purchase on its websites and mobile application directly by customers. It also provides personalized health and wellness products; over-the-counter drug and device products, cosmetics, and supplement products primarily focusing on general wellness, skincare, sexual health and wellness, and hair care under the Hims & Hers brand name; and laboratory testing services to measure a set of biomarkers. Additionally, it offers medical consultation, post-consultation support services, and delivery of laboratory testing results services. Further, the company provides treatments and products for various chronic conditions related to hormone health, weight loss, dermatology, and mental health. The company offers its products through retail partnerships, in stores, and online. The company was formerly known as Hims, Inc. and changed its name to Hims & Hers Health, Inc. in January 2021. The company was founded in 2017 and is based in San Francisco, California.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
19.97
Low
22.47
High
52 Week Price Range
13.74
Low
65.30
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High
AI Summary

Hims & Hers Health Inc operates a direct-to-consumer digital health platform offering telemedicine, prescription and OTC treatments and wellness services across sexual health, dermatology, mental health and primary care. Growth drivers include rising telehealth adoption, category expansion and subscription revenue that may support scale and margin improvement, making the company attractive for investors seeking digital-first healthcare exposure.
Key investment risks include intense competition and customer-acquisition cost pressure, regulatory and reimbursement uncertainty for telemedicine and prescription delivery, and ongoing execution risk to achieve sustained profitability.

Risk Score
Medium

Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.

Key Metrics*

Previous Close
22.94
Dividend Yield
-
Revenue TTM
2578.11M
Revenue Per Share
11.29
Gross Profit TTM
1792.55M
Debt / Equity
2.07
ROE
-32.03%
Net Debt
891.97M
ROCE
7.08%
Diluted EPS TTM
-0.62

Insight News

View All

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Income before tax 123.92M 71.71M -21.57M -65.71M -110.80M
Net income 128.37M 126.04M -23.55M -65.68M -107.66M
Selling general administrative 272.72M 167.77M 129.88M 98.19M 183.63M
Selling and marketing expenses 919.30M 678.84M 446.44M 272.59M 135.90M
Gross profit 1733.38M 1173.13M 714.95M 408.72M 204.49M
Reconciled depreciation 54.50M 17.09M 9.52M 7.47M 4.08M
Ebit 123.92M 71.71M -21.57M -68.70M -115.04M
Ebitda 178.43M 88.80M -12.06M -61.22M -110.52M
Depreciation and amortization 54.50M 17.09M 9.52M 7.47M 4.52M
Non operating income net other - - - - 4.25M
Operating income 105.61M 61.90M -29.45M -68.70M -115.04M
Other operating expenses 2242.02M 1414.61M 901.45M 595.61M 386.92M
Interest expense - - - 2.99M 3.80M
Tax provision -4.44M -54.33M 1.98M -0.03M -3.14M
Net interest income - - - - 0.00M
Income tax expense -4.44M -54.33M 1.98M -0.03M -3.14M
Total revenue 2347.64M 1476.51M 872.00M 526.92M 271.88M
Total operating expenses 1627.77M 1111.23M 744.40M 477.42M 319.54M
Cost of revenue 614.26M 303.38M 157.05M 118.19M 67.38M
Total other income expense net 18.31M 9.81M 7.88M 2.99M 4.25M
Net income from continuing ops 128.37M 126.04M -23.55M -65.68M -107.66M
Net income applicable to common shares - - - -65.68M -107.66M
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Total assets 2154.70M 707.54M 441.19M 366.34M 420.58M
Intangible assets 196.12M 43.41M 18.57M 21.84M 25.89M
Other current assets 42.26M 25.07M 14.86M 15.41M 9.07M
Total liab 1613.78M 230.82M 97.16M 54.60M 85.97M
Total stockholder equity 540.93M 476.72M 344.03M 311.74M 334.62M
Other current liab 129.15M 53.01M 34.38M 12.45M 55.03M
Common stock 0.02M 0.02M 0.02M 0.02M 0.02M
Capital stock 0.02M 0.02M 0.02M 0.02M 0.02M
Retained earnings -113.77M -242.14M -368.18M -344.63M -278.95M
Other liab - - - 3.01M 2.63M
Good will 278.32M 112.73M 110.88M 110.88M 110.88M
Other assets - - 0.00M 0.89M 8.80M
Cash 228.62M 220.58M 96.66M 46.77M 71.78M
Total current liabilities 404.43M 221.37M 88.47M 47.94M 79.22M
Current deferred revenue 127.16M 75.28M 7.73M 1.47M 3.19M
Net debt 891.97M -209.24M -86.72M -41.47M -66.30M
Short term debt 4.84M 1.89M 1.28M 1.66M 1.36M
Short long term debt total 1120.59M 11.35M 9.95M 5.31M 5.48M
Other stockholder equity 652.38M 719.15M 712.31M 656.63M 613.69M
Property plant equipment - - - 7.94M 5.11M
Total current assets 767.64M 395.83M 265.05M 216.59M 269.90M
Long term investments 351.26M 0.00M - - -
Net tangible assets - - - 170.82M 197.85M
Short term investments 348.88M 79.67M 124.32M 132.85M 175.49M
Net receivables 32.15M 6.08M 6.75M 3.23M 3.58M
Long term debt 972.58M - - - -
Inventory 115.73M 64.43M 22.46M 21.56M 13.56M
Accounts payable 143.28M 91.18M 43.07M 32.36M 19.64M
Accumulated other comprehensive income 2.29M -0.32M -0.12M -0.28M -0.14M
Common stock total equity - - - - 0.02M
Retained earnings total equity - - - - -278.95M
Non currrent assets other 29.68M 1.00M 0.95M 12.09M 8.80M
Non current assets total 1387.07M 311.71M 176.13M 149.75M 150.68M
Capital lease obligations 148.01M 11.35M 9.95M 5.31M 5.48M
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Investments -637.14M -19.05M -12.11M 34.70M -104.79M
Change to liabilities - - - 11.01M 11.27M
Total cashflows from investing activities -1024.96M -19.05M -12.11M 34.70M -156.27M
Net borrowings 970.00M 0.00M 0.00M - 1.19M
Total cash from financing activities 729.62M -107.84M -11.47M -33.13M 235.04M
Change to operating activities - - - -17.20M 1.82M
Net income 128.37M 126.04M -23.55M -65.68M -107.66M
Change in cash 8.03M 123.92M 49.89M -25.01M 44.29M
Begin period cash flow 221.44M 97.52M 47.63M 72.64M 28.35M
End period cash flow 228.62M 221.44M 97.52M 47.63M 72.64M
Total cash from operating activities 300.01M 251.08M 73.48M -26.53M -34.41M
Issuance of capital stock - - 0.00M 0.00M 272.69M
Depreciation 54.50M 17.09M 9.52M 7.47M 4.08M
Other cashflows from investing activities -16.55M -11.10M -9.27M - -51.48M
Change to inventory -13.72M -41.61M -0.90M -8.00M -9.63M
Change to account receivables - - - - 1.82M
Sale purchase of stock -89.96M -83.04M -2.00M 0.00M -22.03M
Other cashflows from financing activities -116.67M -24.81M -9.48M -35.37M -15.62M
Change to netincome - - - 45.87M 65.57M
Capital expenditures 226.04M 52.75M 26.49M 7.25M 5.01M
Cash flows other operating - - - - 4.54M
Exchange rate changes - - - - -0.07M
Cash and cash equivalents changes - - - - 44.29M
Change in working capital -29.16M 78.62M 20.82M -14.20M 3.46M
Stock based compensation 135.24M 92.32M 66.08M 42.82M 67.21M
Other non cash items 24.02M -1.34M 0.63M 3.65M 1.89M
Free cash flow 73.96M 198.33M 46.99M -33.78M -39.42M

Peer Comparison*

Sector: Healthcare Industry: Drug Manufacturers - Specialty & Generic

Stock Name
Change
(USD)
Price
(USD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
HIMS
Hims Hers Health Inc		 -2.28
9.94%		 20.66 - 74.63 2.52 20.74 2.88 205.86
MKKGY
Merck KGaA ADR		 0.54
1.63%		 33.71 21.25 14.93 3.10 2.14 3.60 12.98
MKGAF
MERCK Kommanditgesellschaft auf Aktien		 2.58
1.54%		 169.70 24.86 15.11 3.13 1.98 3.08 18.89
TAK
Takeda Pharmaceutical Co Ltd ADR		 -0.31
1.47%		 20.78 - 10.96 0.01 1.20 2.94 23.11
TKPHF
Takeda Pharmaceutical Co. Ltd.		 0.50
1.19%		 42.35 - 10.66 0.01 1.16 2.94 23.11

Profile*

Hims Hers Health Inc

Hims & Hers Health, Inc. operates as a consumer-first health and wellness platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, Canada, Germany, the Republic of Ireland, France, Spain, Australia, and internationally. The company offers a range of curated prescription and non-prescription health and wellness products and services available to purchase on its websites and mobile application directly by customers. It also provides personalized health and wellness products; over-the-counter drug and device products, cosmetics, and supplement products primarily focusing on general wellness, skincare, sexual health and wellness, and hair care under the Hims & Hers brand name; and laboratory testing services to measure a set of biomarkers. Additionally, it offers medical consultation, post-consultation support services, and delivery of laboratory testing results services. Further, the company provides treatments and products for various chronic conditions related to hormone health, weight loss, dermatology, and mental health. The company offers its products through retail partnerships, in stores, and online. The company was formerly known as Hims, Inc. and changed its name to Hims & Hers Health, Inc. in January 2021. The company was founded in 2017 and is based in San Francisco, California.

2269 Chestnut Street, San Francisco, CA, United States, 94123

415 851 0195

https://www.hims.com

2442

Name Title Year Born
Mr. Andrew Dudum Co-Founder, Chairman & CEO 1989
Ms. Melissa Baird Chief Operations Officer 1978
Ms. Irene A. Becklund Principal Accounting Officer 1985
Ms. Soleil Teubner Boughton Chief Legal Officer & Corp. Sec. 1979
Mr. Yemi Okupe Chief Financial Officer 1986
Mr. Brian O'Shaughnessy Chief Communications Officer NA
Ms. Amee Parekh Sr. VP of HR NA
Mr. Mike Chi Chief Growth Officer NA
Mr. Jonathan Spitzer C.F.A. Sr. VP of Investor Relations NA
Dr. Aimee Paik FAAD, M.D. Sr. VP & Member of Medical Advisory Board NA

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Kalkine

3 Mining Stock
Ideas Report

Download a free report with stock ideas and industry insights for general information.

Download Free Report Now → sector image

Top Stocks by Market Cap*

No data available
No data available

Equity Sectors*

  • Basic Materials

    -2.54%

  • Communication Services

    +0.09%

  • Consumer Cyclical

    -0.16%

  • Consumer Defensive

    -0.14%

  • Energy

    -1.11%

  • Financial Services

    +0.15%

  • Healthcare

    -0.77%

  • Industrials

    -0.93%

  • Real Estate

    -0.17%

  • Technology

    -0.09%

  • Utilities

    -0.67%

Note: Daily price change (%) by sector excluding stocks with +/-90% daily price change. Companies above $500 million market capitalization are considered.

Support

Hi! How can we help you today?

Loading…